Hovedparten af de alvorlige bivirkninger var gastrointestinale forstyrrelser (8% - 11 patienter), især kvalme (3% - 4 patienter), opkastning (3% - 4 patienter) og øvre abdominalsmerter (2% - 2 patienter).
The majority of the SARs were gastrointestinal disorders (8% - 11 patients), specifically nausea (3% - 4 patients), vomiting (3% - 4 patients) and upper abdominal pain (2% - 2 patients).